CompletedPhase 3NCT01096368
Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma
Studying Anaplastic ependymoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Children's Oncology Group
- Principal Investigator
- Amy A SmithChildren's Oncology Group
- Intervention
- 3-Dimensional Conformal Radiation Therapy(radiation)
- Enrollment
- 479 enrolled
- Eligibility
- 21 years · All sexes
- Timeline
- 2010 – 2026
Study locations (30)
- Children's Hospital of Alabama, Birmingham, Alabama, United States
- University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States
- Banner Children's at Desert, Mesa, Arizona, United States
- Phoenix Childrens Hospital, Phoenix, Arizona, United States
- Banner University Medical Center - Tucson, Tucson, Arizona, United States
- Arkansas Children's Hospital, Little Rock, Arkansas, United States
- University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
- Kaiser Permanente Downey Medical Center, Downey, California, United States
- City of Hope Comprehensive Cancer Center, Duarte, California, United States
- Loma Linda University Medical Center, Loma Linda, California, United States
- Miller Children's and Women's Hospital Long Beach, Long Beach, California, United States
- Children's Hospital Los Angeles, Los Angeles, California, United States
- Cedars Sinai Medical Center, Los Angeles, California, United States
- Valley Children's Hospital, Madera, California, United States
- UCSF Benioff Children's Hospital Oakland, Oakland, California, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01096368 on ClinicalTrials.govOther trials for Anaplastic ependymoma
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1, PHASE2NCT05278208Lutathera for Treatment of Recurrent or Progressive High-Grade CNS TumorsNationwide Children's Hospital
- RECRUITINGNANCT05057702Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma and EpendymomaUniversity of California, San Francisco
- RECRUITINGPHASE1NCT03750513LET Optimized IMPT in Treating Pediatric Patients With EpendymomaM.D. Anderson Cancer Center